Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03659513 · ClinicalTrials.gov registry record

The Effect of ECMO on the Pharmacokinetics of the Drugs and Their Clinical Efficacy

A clinical trial of Hypoxia and Extracorporeal Membrane Oxygenation Complication, sponsored by University of Pennsylvania.

Completed
Registry status
75
Enrollment target
1
Study location

NCT03659513 is a study of Hypoxia and Extracorporeal Membrane Oxygenation Complication that has completed, run by University of Pennsylvania. The registered enrollment target is 75 participants, below the 3,115-participant average among 39 other Hypoxia trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03659513, a study of Hypoxia and Extracorporeal Membrane Oxygenation Complication, has completed, sponsored by University of Pennsylvania.

COMPLETED
Registry status
75 participants
Enrollment target
1
Study location

Study Summary

This study will examine the pharmacokinetics of the various, routinely given antibiotics, sedatives, and opioids in patients undergoing venous-venous extra-corporal oxygenation (ECMO). Little is known about the distribution and effectiveness of antibiotics in this particular patient population.

Study Locations (1)

Pennsylvania

  • University of Pennsylvania - Philadelphia

Trial Details

FieldValue
Enrollment Target 75 participants
Start Date 2016-09-13
Est. Completion 2022-10-24

Sponsor

University of Pennsylvania

1,423 total trials

What the Registry Record Tells You About NCT03659513

The ClinicalTrials.gov registry entry for NCT03659513 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,115-participant average among 39 other Hypoxia trials with a reported enrollment target (98% lower). The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Hypoxia appearing as the primary indexed condition, and to 0 interventions.

NCT03659513 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT03659513 about?

NCT03659513 is a clinical study titled "The Effect of ECMO on the Pharmacokinetics of the Drugs and Their Clinical Efficacy". This study will examine the pharmacokinetics of the various, routinely given antibiotics, sedatives, and opioids in patients undergoing venous-venous extra-corporal oxygenation (ECMO). Little is known about the distribution and effectiveness of antibiotics in this particular patient population.

What is the current status of trial NCT03659513?

This trial is currently completed. The enrollment target is 75 participants. The study started on 2016-09-13. Estimated completion is 2022-10-24.

What conditions does trial NCT03659513 study?

This clinical trial studies the following conditions: Hypoxia, Extracorporeal Membrane Oxygenation Complication.

Who is sponsoring clinical trial NCT03659513?

This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03659513 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypoxia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.